Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Psoriasis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02899988
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 205
Large-scale testing (Phase 3)Active Not RecruitingNCT06630559
What this trial is testing

Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Celltrion 153
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00646191
What this trial is testing

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 137
Large-scale testing (Phase 3)Study completedNCT01815424
What this trial is testing

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 266
Large-scale testing (Phase 3)Study completedNCT03701763
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 245
Large-scale testing (Phase 3)Active Not RecruitingNCT06611163
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

Who this might be right for
Moderate to Severe Genital Psoriasis
Sun Pharmaceutical Industries Limited 206
Testing effectiveness (Phase 2)Study completedNCT05600036
What this trial is testing

Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alumis Inc 228
Large-scale testing (Phase 3)Study completedNCT00237887
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 1,212
Testing effectiveness (Phase 2)Study completedNCT02969018
What this trial is testing

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Pfizer 212
Not applicableLooking for participantsNCT07370766
What this trial is testing

Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada

Who this might be right for
Psoriasis (PsO)Moderate to Severe Psoriasis
Chronicle Academy 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765628
What this trial is testing

HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Jiangsu Hansoh Pharmaceutical Co., Ltd. 120
Not applicableLooking for participantsNCT04359394
What this trial is testing

International Rare And Severe Psoriasis Expert Network

Who this might be right for
Pustular Psoriasis (PP)
University Hospital, Basel, Switzerland 180
Not applicableActive Not RecruitingNCT03218488
What this trial is testing

A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag International NV 135
Early research (Phase 1)UnknownNCT02918123
What this trial is testing

Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Kang Stem Biotech Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT01090427
What this trial is testing

The Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 110
Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Early research (Phase 1)Study completedNCT01577550
What this trial is testing

Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

Who this might be right for
Psoriasis
AbbVie 39
Large-scale testing (Phase 3)Study completedNCT00626002
What this trial is testing

Open Label Continuation Study in Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 2,301
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation